| P2093 | author name string | Anna Trzeciakiewicz | |
| | Marie-Noëlle Horcajada | |
| | Véronique Habauzit | |
| P2860 | cites work | Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling | Q46981367 |
| | Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies | Q48360114 |
| | Expression profile of osteoblast lineage at defined stages of differentiation. | Q50771209 |
| | Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. | Q50974876 |
| | Regulation of skeletal development by the Runx family of transcription factors. | Q50974881 |
| | Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. | Q53562030 |
| | Strain-derived canalicular fluid flow regulates osteoclast activity in a remodelling osteon—a proposal | Q57101634 |
| | Osteoporosis | Q57417202 |
| | Modular feedback | Q59006571 |
| | Osteoclasts derived from haematopoietic stem cells | Q59056486 |
| | Sex steroids and bone | Q74124341 |
| | Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation | Q80775405 |
| | Osteoporosis | Q81776893 |
| | The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation | Q24292169 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4 | Q24315313 |
| | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | Structural basis of BMP signalling inhibition by the cystine knot protein Noggin | Q27640149 |
| | Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 |
| | Flavonoids: antioxidants or signalling molecules? | Q28250292 |
| | Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta | Q28283637 |
| | Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies | Q29617784 |
| | Polyphenols: food sources and bioavailability | Q29618132 |
| | Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids | Q30452982 |
| | Role of canonical glucocorticoid responsive elements in modulating expression of genes regulated by the arylhydrocarbon receptor | Q33538241 |
| | Bone health: the role of micronutrients | Q33880728 |
| | Nutrition in bone health revisited: a story beyond calcium | Q33934269 |
| | How should we assess the effects of exposure to dietary polyphenols in vitro? | Q33979300 |
| | Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. | Q34009597 |
| | Cbfa1: a molecular switch in osteoblast biology | Q34085710 |
| | Mechanisms of estrogen action | Q34093297 |
| | Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling | Q34125163 |
| | Estrogen receptor interaction with estrogen response elements | Q34307898 |
| | Growth factors to stimulate bone formation | Q34336778 |
| | Biology of bone and how it orchestrates the form and function of the skeleton | Q34444241 |
| | Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta. | Q34454780 |
| | Structure-function relationship of estrogen receptor alpha and beta: impact on human health | Q34558007 |
| | Estrogen deficiency and bone loss: an inflammatory tale | Q34576622 |
| | Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones | Q34587961 |
| | Regulatory mechanisms of osteoblast and osteoclast differentiation | Q34728971 |
| | Mechanical strain and bone cell function: a review | Q34796375 |
| | Functions of AP1 (Fos/Jun) in bone development | Q34963037 |
| | MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide | Q34977017 |
| | Bioactive substances of plant origin in food--impact on genomics | Q35049231 |
| | Nutrigenomics: goals and strategies. | Q35097356 |
| | Bone morphogenetic proteins, their antagonists, and the skeleton | Q35109618 |
| | Nongenomic steroid action: controversies, questions, and answers | Q35169916 |
| | Wnt signaling in osteoblasts and bone diseases | Q35913119 |
| | Cardiovascular protective effects of resveratrol | Q35922166 |
| | Local and systemic control of the osteoblast | Q36010759 |
| | Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems | Q36051335 |
| | BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk | Q36116637 |
| | In vitro biological properties of flavonoid conjugates found in vivo. | Q36203524 |
| | Dietary polyphenols and the prevention of diseases. | Q36209077 |
| | Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells | Q36230062 |
| | The insulin-like growth factor-I gene and osteoporosis: a critical appraisal | Q36267400 |
| | Nutritional modulators of bone remodeling during aging | Q36392592 |
| | Molecular targets for the cancer preventive activity of tea polyphenols | Q36465473 |
| | Signaling and transcriptional regulation in osteoblast commitment and differentiation | Q36606452 |
| | Bone health | Q36701937 |
| | Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression | Q36802879 |
| | Transcription factors controlling osteoblastogenesis | Q37106754 |
| | Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis | Q37145639 |
| | NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. | Q37349742 |
| | Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts | Q37388231 |
| | Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2 cells. | Q38335836 |
| | Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. | Q40130225 |
| | Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway | Q40206966 |
| | (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts | Q40221790 |
| | Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production | Q40222828 |
| | Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells | Q40325688 |
| | Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. | Q40371682 |
| | Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens | Q40429042 |
| | Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. | Q40491807 |
| | BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. | Q40636491 |
| | Flavonoid phytochemicals regulate activator protein-1 signal transduction pathways in endometrial and kidney stable cell lines. | Q40720664 |
| | Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. | Q40753097 |
| | Stimulatory effect of Daidzein in osteoblastic MC3T3-E1 cells | Q40902091 |
| | Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4. | Q41154242 |
| | The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. | Q41462180 |
| | Role of osteoblasts in hormonal control of bone resorption—A hypothesis | Q41551873 |
| | Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor | Q42139985 |
| | Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. | Q42485386 |
| | Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process | Q42810838 |
| | Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I. | Q42812786 |
| | Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression | Q42814884 |
| | Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. | Q42816517 |
| | Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells | Q42820449 |
| | Quercetin accelerates TNF-alpha-induced apoptosis of MC3T3-E1 osteoblastic cells through caspase-dependent and JNK-mediated pathways | Q42820829 |
| | Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse | Q43681246 |
| | Flavonoid glucuronides are substrates for human liver beta-glucuronidase | Q43713502 |
| | Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate | Q43767382 |
| | Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes | Q43792260 |
| | Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway | Q44084659 |
| | Reversal of bone loss in mice by nongenotropic signaling of sex steroids | Q44193903 |
| | Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells | Q44650227 |
| | Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway | Q44795237 |
| | A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets | Q44918623 |
| | Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity | Q45110715 |
| | Erk pathways negatively regulate matrix mineralization | Q46281087 |
| | Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells | Q46281124 |
| | A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro | Q46474717 |
| | Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells | Q46546839 |
| | Quercetin and its in vivo metabolites inhibit neutrophil-mediated low-density lipoprotein oxidation | Q46613545 |
| | Simultaneous determination of icariin, icariside II and osthole in rat plasma after oral administration of the extract of Gushudan (a Chinese compound formulation) by LC-MS/MS. | Q46897942 |
| | Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. | Q46916557 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polyphenol | Q290439 |
| | osteoblast | Q917177 |
| P304 | page(s) | 68-81 | |
| P577 | publication date | 2009-02-26 | |
| P1433 | published in | Nutrition Research Reviews | Q15757719 |
| P1476 | title | When nutrition interacts with osteoblast function: molecular mechanisms of polyphenols | |
| P478 | volume | 22 | |